Ophthalmic chloramphenicol drops are commonly used in Western medicine for treating bacterial conjunctivitis. While there are isolated reports of aplastic anemia associated with these eye drops, the risk is considered very low, estimated at less than 1 in 224,716 prescriptions. Some sources suggest that the connection between chloramphenicol eye drops and aplastic anemia is not well established. In Mexico, chloramphenicol is also used prophylactically in newborns. Overall, the safety of ophthalmic chloramphenicol remains a topic of discussion, with no definitive conclusions drawn regarding its association with aplastic anemia.
